Non-profit website: free to use. No fees from patients, hospitals or doctors. Not an agency. · Free · Not an agencyAbout this site
Hematology · Peking University People's Hospital · Beijing

Dr. Wang Fengrong王峰蓉

Associate Chief Physician

Summary compiled from public information, updated 18 Nov 2026. It has not been checked against the hospital website yet. Confirm details with the hospital before you travel.

WF

Professional overview

Wang Fengrong is an Associate Chief Physician at the Institute of Hematology of Peking University People's Hospital, specializing in hematologic diseases and hematopoietic stem cell transplantation.

SpecialtyHematology
Clinical titleAssociate Chief Physician
Academic roles—
DepartmentInstitute of Hematology
HospitalPeking University People's Hospital
CityBeijing

Areas of focus

Hematologic diseasesSpecializes in hematologic diseases
Hematopoietic stem cell transplantationSpecializes in hematopoietic stem cell transplantation

Background

  • 2002Received MD degree from Peking University Health Science Center

Experience & recognition

  • Completed postdoctoral training at Winship Cancer Institute, Emory University, USA
  • Participated in experimental research on arsenic-based agents and novel anti-leukemia drugs, including mechanism studies
  • Conducted research on infection regulation after hematopoietic stem cell transplantation and CXCR4-mediated hematopoietic stem cell mobilization
  • Published over 10 papers in Chinese and English journals
  • Contributed to multiple professional monographs

Professional roles

  • Youth Committee Member, Medical Cell Biology Society, Chinese Medical Association (CMA)
  • International Member, American Society of Hematology (ASH)

Frequently asked questions

What does Dr. Wang Fengrong specialize in?

Specializes in hematologic diseases and hematopoietic stem cell transplantation

Which hospital and department is Dr. Wang Fengrong in?

Institute of Hematology of Peking University People's Hospital

Sources

Dr. Wang Fengrong has not reviewed this page.